Journal: bioRxiv
Article Title: Two axolotl-adapted cell-ablation platforms reveal macrophage-dependent processes essential for spinal-cord and skeletal regeneration
doi: 10.64898/2026.02.10.705144
Figure Lengend Snippet: Tail amputations were performed on germline F1 CD68:NTR 2.0-P2A-tdTomato (CD68:NTR 2.0) or CD68:mScarlet-IRES-ihCasp9 (CD68:IRES-ihCasp9) transgenic larvae alongside age and size matched wildtype d/d then subjected to repeated inducible drug treatments to maintain macrophage depletion throughout the regenerative process. (A) Experimental timeline of NTR 2.0 macrophage ablation and non-sensitized d/d toxicity evaluation shows chronic (14 day – long red arrow) versus four acute (18 hours every 3 days - red solid blocks) doses of MTZ administered through waterborne immersion (WB) with imaging schedule. Imaging timepoints shown with microscope icon and time relative to amputation. (B) Experimental timeline of ihCasp9 macrophage ablation and non-sensitized d/d toxicity evaluation shows 10 mg/kg B/B intraperitoneal injection ( i.p. ) regimen (every 2 days for 23 days) with imagining schedule. Timepoints with i.p. drug delivery of B/B shown in magenta. Imaging timepoints shown with microscope icon and time relative to amputation. (C, D) Representative extended depth of focus projections show CD68:NTR 2.0 transgenic tails at 2 and 14 DPA: (C) 1% DMSO vehicle control, (D) chronic 1 mM MTZ-treated (N=5 animals per treatment, 2-month-old, 2-3 cm length). Amputation plane indicated by white dotted line and cyan boxed regions mark the inset location. (C’, D’) Insets show decreased CD68:NTR 2.0 recruitment and rounded macrophage morphology within the regenerative zone when treated with MTZ relative to DMSO control. Thin white dotted lines outline the spinal cord (dorsal) and cartilage (ventral). Scale Bar: 500 µm. Inset Scale Bar: 100 µm. (E, F) Representative extended depth of focus projections show CD68:IRES-ihCasp9 transgenic tails at 2 and 14 DPA: (E) vehicle control, (F) 10 mg/kg B/B-treated (N=3-5 animals per treatment, 2-month-old, 2-3 cm length). Amputation plane indicated by white dotted line and cyan boxed regions mark the inset location. (E’, F’) Insets show fragmented CD68:IRES-ihCasp9 debris with complete inhibition of both cartilage and spinal cord regeneration relative to the vehicle control. Thin white dotted lines outline the spinal cord (dorsal) and cartilage (ventral). Scale Bar: 500 µm. Inset Scale Bar: 100 µm. (G) Quantitative morphometric analysis of tail regenerates in CD68:NTR 2.0 transgenics (solid lines) and non-sensitized d/d controls (dashed lines) treated with MTZ. Measurements of cartilage length, spinal cord length, and epithelial surface area that extend beyond the amputation plane were collected at 2, 7, 14, and 21 DPA in Fiji (N=5 animals per treatment, 2-month-old, 2-3 cm length). (H) Quantitative morphometric analysis of tail regenerates in CD68:IRES-ihCasp9 transgenics (solid lines) and non-sensitized d/d controls (dashed lines) shows cartilage length, spinal cord length, and epithelial surface area relative to amputation plane measured at 2, 7, 14, and 21 DPA in Fiji (N=3-5 animals per treatment, 2-month-old, 2-3 cm length). (I) Representative maximum intensity projections of Victoria blue stained CD68:IRES-ihCasp9 transgenic tails at 21 DPA demonstrate regenerative failure following amputation of the cartilaginous rod in B/B-treated animals compared to the vehicle-treated controls (N=3 animals per treatment, 2-month-old, 2-3 cm length). Amputation plane indicated by white dotted line. Scale Bar: 100 µm. (J) Representative confocal maximum intensity projections of vehicle-versus B/B-treated CD68:IRES-ihCasp9 transgenic tails stained with DAPI (blue), βIII-tubulin + axons (green), GFAP⁺ radial glial cells (magenta), and collagen I (yellow) at 21 DPA (N=3 animals per treatment, 2-month-old, 2-3 cm length). Amputation plane indicated by white dotted line. Scale Bar: 100 µm. Error bars represent mean ± SD. Statistical significance of inducible drug treatments relative to the respective vehicle controls at each regenerative timepoint was determined by two-way ANOVA with Tukey’s multiple comparisons test (* p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001). MTZ=Metronidazole (NTR 2.0 prodrug), B/B=AP20187 (ihCasp9 homodimerizer), DPA=Days post-amputation.
Article Snippet: DAPI, tdTomato, NucView 488, and CF640R fluorescence was excited and collected by using Zeiss DAPI filter cube set 49 (ref: 488049-9901-000), Zeiss EGFP filter cube set 38 HE (ref: 89038-9901-000), Zeiss mCherry filter cube set 63 HE (ref: 489063-0000-000), and Zeiss Cy5 filter cube set 50 (ref: 488050-9901-000) respectively.
Techniques: Transgenic Assay, Imaging, Microscopy, Injection, Control, Inhibition, Staining